Join
Live feed
·
PRReleasevia Quantisnow
Tvardi Therapeutics Inc. logo

New Preclinical Data Further Support Potential for Tvardi’s STAT3 Inhibitors in Ulcerative Colitis (UC)

ByQuantisnow·Wall Street's wire, on your screen.
TVRD· Tvardi Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TVRD (Tvardi Therapeutics Inc.) and more on Quantisnow.